Search Results

You are looking at 71 - 80 of 128 items for :

  • Refine by Access: All x
Clear All
Full access

Gene A. Wetzstein, Dima Decker, and James Mond

COVID 19 pandemic; (2) identify the most common respiratory viral pathogens; (3) explore current management approaches and prescriber satisfaction; and (4) explore unmet need and future therapies. Methods: This prospective medical questionnaire was

Full access

Kedar Kirtane, Jameel Muzaffar, Julie Kish, Laura B Oswald, Brian D Gonzalez, Taylor Welniak, Yvelise Rodriguez, and Christine H Chung

to worsening of their medical condition. Due to the COVID-19 pandemic, the trial was closed for the eight months but is now open to accrual. Conclusions : This trial is currently open and accruing patients. Feasibility will be analyzed after

Full access

Michelle C Simpson and Danell J Haines

INTRODUCTION : The advent of the COVID-19 pandemic has highlighted the need to expand options for home-based cancer care. For 40 years, millions of patients have selected the home setting to administer infused medications citing improved quality

Full access

Lilian Hanna, Gordon Taylor Moffat, Wilma Hopman, Pierre-Olivier Gaudreau, and Andrea S. Fung

exploring alternate dosing schedules. The COVID-19 pandemic created a need to cut down on patient visits, thus allowing incorporation of extended dosing (ED) of durvalumab (20mg/kg IV every 4 weeks) into clinical practice. The current study evaluates real

Full access

Margaret Tempero

being able to stay home and have the conversation there. Thus, even when we ditch the masks, I think for at least some established patients, this will remain the norm. When COVID-19 shut down San Francisco last April, I believed the shutdown would last

Full access

Margaret Tempero

Thanks to COVID-19, I am still sheltering in place in San Francisco, wondering if I will ever again be able to get a haircut or hug a friend that I meet on the street. Some states are “opening up” while cases of COVID-19 are still climbing, and new

Full access

Margaret Tempero

first COVID-19 vaccination. The fact that, as of writing, 2 vaccines have FDA approval and more are on the way is nothing short of miraculous. The increase in production by the industry giants responsible for these vaccines has also been a tour de force

Full access

Margaret Tempero

Dear Santa, It’s Margaret here. Gosh, a lot has happened since I wrote you last year. I do hope that you, Mrs. Claus, and the elves have been safe this year, as I imagine COVID-19 found its way even to the North Pole. But I know you! I believe

Full access

Margaret Tempero

have our colleagues in the emergency department, ICU, and COVID-19 floors. Those colleagues are true heroes, and we must remember to acknowledge and be grateful for their sacrifices in the years ahead. I could add more, but this is a start. We still

Full access

precautions for COVID-19, and I didn’t even get a black market haircut or a manicure. And I haven’t attended any parties. So here are my top 10 requests this year, in no particular order: Give President-elect Joe Biden “medicine” to heal the country Bring an